MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Alphatec Holdings Operating Income 2011-2026 | ATEC
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Alphatec Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -82.1 M | -136 M | -173 M | -147 M | -128 M | -58.9 M | -47.3 M | -22.4 M | -9 M | -15.4 M | -176 M | 1.48 M | -73.4 M | -9.84 M | -24.5 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.48 M | -176 M | -73.5 M |
Quarterly Operating Income Alphatec Holdings
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -13.1 M | -44.3 M | - | -33.7 M | -35.3 M | -43.3 M | - | -38.4 M | -49.9 M | -40.3 M | - | -35 M | -35.7 M | -41.2 M | - | -35.1 M | -35.8 M | -19 M | - | -12.9 M | -11.2 M | -17.8 M | - | -11.6 M | -10.4 M | -10.8 M | - | -7.53 M | -6.54 M | -667 K | - | -1.26 M | -735 K | -3.4 M | - | -4.55 M | -320 K | -3.44 M | - | -165 M | -2.83 M | 1.14 M | - | 1.73 M | 1.84 M | -4.7 M | - | -13.2 M | -2.9 M | -1.36 M | - | -1.97 M | -3.75 M | -126 K | - | -2.36 M | -3.3 M | -2.36 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.84 M | -165 M | -18.2 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M |  USA |
 |
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
90.9 M | $ 11.94 | -1.08 % | $ 1.61 B | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
ClearPoint Neuro
CLPT
|
-24.2 M | $ 9.07 | -3.3 % | $ 257 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
9.66 M | $ 23.78 | 0.72 % | $ 201 M | USA |
 |
Bruker Corporation
BRKR
|
253 M | $ 36.67 | -0.19 % | $ 5.46 K | USA |
 |
Second Sight Medical Products
EYES
|
-27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
Globus Medical
GMED
|
480 M | $ 90.0 | 1.58 % | $ 12.2 B | USA |
 |
FONAR Corporation
FONR
|
5.31 M | $ 18.58 | -0.11 % | $ 122 M | USA |
 |
Helius Medical Technologies
HSDT
|
-12.4 M | $ 1.83 | -3.68 % | $ 1.11 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
28.4 M | $ 9.33 | 0.21 % | $ 719 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-19.8 M | $ 3.4 | -1.73 % | $ 127 M |  France |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
IRIDEX Corporation
IRIX
|
-2.57 M | $ 1.03 | 3.35 % | $ 17.4 M | USA |
 |
Integer Holdings Corporation
ITGR
|
221 M | $ 85.11 | -0.61 % | $ 2.96 B | USA |
 |
Align Technology
ALGN
|
608 M | $ 166.87 | -2.91 % | $ 12.5 B | USA |
 |
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | USA |
 |
AxoGen
AXGN
|
-7.85 M | $ 30.99 | -5.06 % | $ 1.43 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-39.2 M | $ 15.76 | -1.13 % | $ 370 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
LENSAR
LNSR
|
-24.6 M | $ 5.63 | -4.41 % | $ 67.3 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
Medtronic PLC
MDT
|
5.96 B | $ 86.42 | 0.15 % | $ 111 B | USA |
 |
Myomo
MYO
|
-14.4 M | $ 0.68 | -2.9 % | $ 28.5 M | USA |
 |
Butterfly Network
BFLY
|
-74.4 M | $ 4.05 | -1.94 % | $ 857 M | USA |
 |
Nevro Corp.
NVRO
|
-126 M | - | - | $ 217 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-14.7 M | $ 0.61 | 3.37 % | $ 38 M | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
660 K | $ 9.67 | -0.31 % | $ 346 M | USA |
 |
BioSig Technologies
BSGM
|
-71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
3.61 B | $ 61.86 | -1.12 % | $ 91.6 B | USA |
 |
Insulet Corporation
PODD
|
474 M | $ 202.46 | -0.51 % | $ 14.2 B | USA |
 |
CONMED Corporation
CNMD
|
103 M | $ 34.54 | 1.35 % | $ 1.07 B | USA |